160 related articles for article (PubMed ID: 19184977)
1. A finite mixture survival model to characterize risk groups of neuroblastoma.
Hunsberger S; Albert PS; London WB
Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977
[TBL] [Abstract][Full Text] [Related]
2. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
3. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
4. [Management strategy in neuroblastoma].
Balwierz W
Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
[TBL] [Abstract][Full Text] [Related]
5. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
Newman EA; Nuchtern JG
Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
[TBL] [Abstract][Full Text] [Related]
6. Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.
Depuydt P; Boeva V; Hocking TD; Cannoodt R; Ambros IM; Ambros PF; Asgharzadeh S; Attiyeh EF; Combaret V; Defferrari R; Fischer M; Hero B; Hogarty MD; Irwin MS; Koster J; Kreissman S; Ladenstein R; Lapouble E; Laureys G; London WB; Mazzocco K; Nakagawara A; Noguera R; Ohira M; Park JR; Pötschger U; Theissen J; Tonini GP; Valteau-Couanet D; Varesio L; Versteeg R; Speleman F; Maris JM; Schleiermacher G; De Preter K
J Natl Cancer Inst; 2018 Oct; 110(10):1084-1093. PubMed ID: 29514301
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma in adults and adolescents: an indolent course with poor survival.
Franks LM; Bollen A; Seeger RC; Stram DO; Matthay KK
Cancer; 1997 May; 79(10):2028-35. PubMed ID: 9149032
[TBL] [Abstract][Full Text] [Related]
8. Update on neuroblastoma.
Newman EA; Abdessalam S; Aldrink JH; Austin M; Heaton TE; Bruny J; Ehrlich P; Dasgupta R; Baertschiger RM; Lautz TB; Rhee DS; Langham MR; Malek MM; Meyers RL; Nathan JD; Weil BR; Polites S; Madonna MB;
J Pediatr Surg; 2019 Mar; 54(3):383-389. PubMed ID: 30305231
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma: an enigmatic disease.
Brossard J; Bernstein ML; Lemieux B
Br Med Bull; 1996 Oct; 52(4):787-801. PubMed ID: 9039732
[TBL] [Abstract][Full Text] [Related]
10. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
Owens C; Irwin M
Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma in southern Brazil: an 11-year study.
Parise IZ; Haddad BR; Cavalli LR; Pianovski MA; Maggio EM; Parise GA; Watanabe FM; Ioshii SO; Rone JD; Caleffe LG; Odone Filho V; Figueiredo BC
J Pediatr Hematol Oncol; 2006 Feb; 28(2):82-7. PubMed ID: 16462579
[TBL] [Abstract][Full Text] [Related]
14. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
[TBL] [Abstract][Full Text] [Related]
16. Risk-directed therapy and research in neuroblastoma.
Liu YL; Miser JS; Hsu WM
J Formos Med Assoc; 2014 Dec; 113(12):887-9. PubMed ID: 25499951
[No Abstract] [Full Text] [Related]
17. Neuroblastoma.
Castleberry RP
Eur J Cancer; 1997 Aug; 33(9):1430-7; discussion 1437-8. PubMed ID: 9337686
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors.
Zobel M; Zamora A; Sura A; Wang L; Stein J; Marachelian A; Kim ES
J Surg Res; 2020 May; 249():8-12. PubMed ID: 31918331
[TBL] [Abstract][Full Text] [Related]
19. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma.
Kaneko M; Tsuchida Y; Uchino J; Takeda T; Iwafuchi M; Ohnuma N; Mugishima H; Yokoyama J; Nishihira H; Nakada K; Sasaki S; Sawada T; Kawa K; Nagahara N; Suita S; Sawaguchi S
J Pediatr Hematol Oncol; 1999; 21(3):190-7. PubMed ID: 10363851
[TBL] [Abstract][Full Text] [Related]
20. Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
Bagatell R; Beck-Popovic M; London WB; Zhang Y; Pearson AD; Matthay KK; Monclair T; Ambros PF; Cohn SL;
J Clin Oncol; 2009 Jan; 27(3):365-70. PubMed ID: 19047282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
